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Lekarz Dariusz Gach to absolwent Wydziału Lekarskiego Śląskiego Uniwersytetu Medycznego w Katowicach; obecnie 
w trakcie szkolenia specjalizacyjnego z kardiologii. Jest lekarzem rezydentem, zatrudnionym na Oddziale Kardiologii 
ze stanowiskami intensywnego nadzoru kardiologicznego Szpitala Wojewódzkiego w Bielsku-Białej, gdzie pracuje pod 
kierownictwem dr. n. med. Wojciecha Jaszczurowskiego. Działania oddziału obejmują diagnostykę i leczenie chorób 
układu sercowo-naczyniowego oraz realizację procedur elektroterapii.
W ramach działalności naukowej dr Gach współpracuje z Oddziałem Klinicznym Kardioanestezji i Intensywnej Terapii 
Śląskiego Centrum Chorób Serca w Zabrzu, gdzie pod opieką dr. hab. n. med. Łukasza Krzycha rozwija swoje zain-
teresowania intensywną terapią kardiologiczną, zwłaszcza w zakresie diagnostyki i terapii chorób układu krążenia 
u młodych dorosłych. Zainteresowania medyczne dr. Gacha obejmują procedury inwazyjnej diagnostyki kardiologicznej, 
elektroterapii i intensywnej terapii kardiologicznej. W wolnym czasie zajmuje się sportem oraz turystyką górską.
Abstract
Introduction. Myocarditis is a challenging diagnosis due to the heterogeneity of clinical presentations. This inflammatory 
myocardial disease should be diagnosed based on established clinical, laboratory and imaging criteria.
Material and methods. We studied consecutive patients aged 18–40 years admitted to an emergency department 
(ED) with the diagnosis of an acute coronary syndrome (ACS) between January 01, 2011 and December 31, 2013. 
Demographic, clinical and laboratory data were analysed. The patients were diagnosed with myocarditis based on the 
history of a respiratory or gastrointestinal tract infection, clinical symptoms of reduced exercise tolerance, chest pain, 
arrhythmias or new onset symptoms of heart failure, with abnormal electrocardiographic and/or echocardiographic 
findings and elevated markers of myocardial necrosis. All subjects underwent coronary angiography to exclude or 
confirm an ACS.
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Results. Patients with myocarditis were younger (median age 30.5 years, interquartile range [IQR] 20.5–32) compared 
to ACS patients (median age 39 years, IQR 35–39.5; (p = 0.001). All young adults with myocarditis had a history of 
infection within 4 weeks and it was the strongest determinant of myocarditis (odds ratio [OR] 113.7, 95% confidence 
interval [CI] 5.64–2289.7; p < 0.001). Compared to ACS patients, those with myocarditis were more likely to report 
a history of fever (OR 17.22; 95% CI 0.9–330.5; p = 0.06) and have an elevated white blood cell count (median 9.95, 
IQR 8.3–11.95 vs. 8.2, IQR 6.4–10.32; p = 0.07), elevated high-sensitivity C-reactive protein level (OR 29.3; 95% CI 
1.14–748.6; p = 0.04), higher left ventricular ejection fraction (median 60, IQR 60–65 vs. 55, IQR 50–55; p = 0.001), 
and elevated creatine kinase activity (OR 7.94; 95% CI 1.41–44.8; p = 0.02). Dyslipidaemia was less frequent in young 
adults with myocarditis (OR 0.03; 95% CI 0.003–0.3; p = 0.002).
Conclusions. Infection-related parameters are key determinants of myocarditis in young adults with chest pain. These 
easily accessible clinical and laboratory parameters should guide further clinical decision-making in ED.
Key words: myocarditis, acute coronary syndrome, young adults
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hospital, referred with a diagnosis of an ACS from Januwary 
01, 2011 to December 31, 2013.
In addition to detailed history, laboratory tests perfor-
med in all patients included markers of myocardial damage 
(high-sensitivity troponin T [hsTnT], creatine kinase (CK) 
and its MB isoenzyme (CK-MB), inflammatory markers inclu-
ding leukocyte count and high-sensitivity C-reactive protein 
(hsCRP), and serum lipid profile. All patients underwent 
serial electrocardiograms (ECG) and echocardiographic 
examinations to evaluate cardiac chamber volumes and 
global and regional left ventricular systolic function, and 
were referred to a cardiac catheterization laboratory to 
perform coronary angiography.
The diagnosis of myocarditis was made by exclusion, 
based on typical history (a history of an upper respiratory 
tract or gastrointestinal infection), clinical symptoms 
(impaired effort tolerance, chest pain, arrhythmia and/or 
conduction disturbances, new-onset symptoms of heart fa-
ilure), ECG and echocardiographic findings, and laboratory 
parameters when coronary angiography revealed normal 
coronary arteries.
Ultimately, the study group included 20 young adults 
with myocarditis, and the control group consisted of 15 pa-
tients with an angiographically confirmed ACS.
Statistical analysis was performed using MedCalc 
software (v.13). Qualitative variables were presented as 
absolute values and/or proportions, and quantitative va-
riables as median values and interquartile ranges (IQR). 
Between-group differences in quantitative variables were 
evaluated using the Student t test for normally distributed 
variables and the Mann-Whitney U test for non-normally 
distributed variables. Normal distribution of variables was 
verified using the Kolmogorov-Smirnov test. Differences in 
qualitative variables were evaluated using the chi-square 
test or the exact Fisher test. Additionally, associations 
between dichotomous variables were shown as odds 
Introduction
Myocarditis is often a diagnostic challenge due to hetero-
geneity of its clinical presentation [1–5]. Its course may be 
fulminant (with clear acute onset and rapid progression of 
heart failure symptoms including development of cardioge-
nic shock), acute (resembling an acute coronary syndrome), 
subacute (taking a more indolent course, with cardiac 
dysfunction usually leading to dilated cardiomyopathy) or 
chronic (with progressive heart failure) [5].
This inflammatory myocardial disease should be diag-
nosed based on defined clinical and laboratory criteria 
(including immunological, histological and immunohisto-
chemical) and imaging study findings [5]. In routine clinical 
practice, however, this diagnosis is made by exclusion of 
other conditions, primarily an acute coronary syndrome 
(ACS) [5, 6].
Due to these difficulties, the prevalence of myocarditis 
is difficult to determine [3, 5, 6]. Based on autopsy studies, 
it has been suggested that myocarditis may underlie up to 
42% of sudden cardiac deaths among young adults [7, 8], 
while biopsy-based studies indicate that myocarditis may 
be responsible for 16% of cases of non-ischaemic cardio-
myopathy in adults [9, 10] and even 46% of such cases 
in children [11]. Increasingly restricted indications for 
endomyocardial biopsy make these estimates even more 
difficult [2].
The aim of the study was to identify simple, easily ac-
cessible clinical and laboratory determinants of myocarditis 
in young adults referred to an emergency department with 
a suspicion of an ACS.
Material and methods
We studied consecutive patients aged 18–40 years admit-
ted to the emergency department of a secondary referral 
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Figure 1. Patient age; ACS — acute coronary syndrome
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ratios (OR) with 95% confidence intervals (CI). P < 0.05 
was considered statistically significant.
Results
The study included 35 patients aged 18–40 years (median 
32 years, IQR 28–39), including 20 (57.1%) patients with 
myocarditis and 15 (42.9%) patients with an ACS. Patients 
with myocarditis were significantly younger (median age 
30.5 years, IQR 20.5–32) than patients with an ACS (me-
dian age 39 years, IQR 35–39.5; p = 0.001; Figure 1). 
Eighty-three percent of patients were men, but gender was 
not a group determinant (OR 3.28, 95% CI 0.51–20.9; p 
= 0.4).
All patients with myocarditis had a history of an infec-
tion within 4 weeks, mostly a respiratory tract infection. 
This parameter was the strongest determinant of myocar-
ditis (OR 113.7). Duration of infection was 4 (IQR 3.5–7) 
days. Patients with myocarditis were also characterized 
by more frequent history of fever (p = 0.06), a higher 
number of leukocytes in peripheral blood (p = 0.07), 
and an increased hsCRP level (p = 0.04). A comparison 
of infection-related variables, including OR and 95% CI 
values, is shown in Table 1.
A comparison of myocardial dysfunction-related pa-
rameters is shown in Table 2. We found no significant 
differences in most evaluated parameters. Patients with an 
ACS were characterized by significantly lower left ventricular 
ejection fraction (p = 0.001), although the proportion of 
patients with impaired left ventricular systolic function did 
not differ between the groups (p = 0.8). Young adults with 
myocarditis were 8 times more likely to have an elevated 
CK level (p = 0.02).
The burden of conventional cardiovascular risk factors 
did not differ between the two groups, except for dyslipi-
daemia which was much less common among patients 
with myocarditis (p = 0.002). These data are summarized 
in Table 3.
Patients were most commonly hospitalized during 
spring but no relation was found between seasonal inci-
dence variation and the final diagnosis (p = 0.2) (Figure 2).
Outcomes were favourable in both groups, with all 
patients discharged home in a good general condition. 
Duration of hospitalization was 7.5 (IQR 7–8) days.
Table 1. Infection-related parameters
Parameter Overall Myocarditis ACS OR (95% CI) p
History of infection  
within last 4 weeks
16 (45.7%) 16 (80%) 0 113.7 (5.64–2289.7) < 0.001
Respiratory tract  
infection
12 (34.3%) 12 (60%) 0 45.6 (2.39–869.2) < 0.001
Gastrointestinal tract 
infection
2 (5.7%) 2 (10%) 0 4.19 (0.19–94.0) 0.4
History of fever within 
last 4 weeks
7 (20%) 7 (35%) 0 17.22 (0.9–330.5) 0.06
Baseline WBC count 
[103/mm3]
9.1 (7.13; 11.3) 9.95 (8.3; 11.95) 8.2 (6.4; 10.32) – 0.07
Patients with elevated 
baseline WBC count
14 (40%) 10 (50%) 4 (26.7%) 2.75 (0.65–11.62) 0.3
Baseline hsCRP level 44.7 (19.3; 62.4) 50.7 (30.1; 62.7) 11.8 (3.2; 41.1) – 0.2
Patients with elevated 
baseline hsCRP level
23 (65.7%) 20 (100%) 3 (20%) 29.3 (1.14; 748.6) 0.04
ACS — acute coronary syndrome; OR — odds ratio; CI — confidence interval; WBC — white blood cell; hsCRP — high-sensitivity C-reactive protein
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Table 2. Parameters of myocardial dysfunction and damage
Parameter Overall Myocarditis ACS OR (95% CI) p
Baseline hsTnT [pg/mL] 860.2 (451.8; 1268) 814.4 (502.3; 1289) 885.6 (325.3; 1261) – 0.7
Baseline CK [U/L] 440 (250; 592) 419 (244; 483) 2046 (602; 3491) – 0.06
Patients with elevated  
baseline CK
13 (37.1%) 11 (55%) 2 (10%) 7.94 (1.41; 44.8) 0.02
Baseline CK-MB [U/L] 41.0 (23.5; 83.9) 39.1 (23.6; 57) 92.3 (33.4; 277.3) – 0.4
Patients with elevated  
baseline CK-MB
11 (31.4%) 9 (45%) 2 (13.3%) 1.12 (0.08–16.3) 0.5
Baseline NT-proBNP [pg/mL] 326.0 (169.5; 1024.5) 495.0 (174; 1630) 205.0 (84; 326) – 0.1
LVEF (%) 60 (52; 60) 60 (60; 65) 55 (50; 55) – 0.001
Patients with LVEF < 50% 3 (8.6%) 1 (5%) 2 (13.3%) 0.34 (0.03; 4.2) 0.8
Ventricular arrhythmia 2 (5.7%) 2 (10%) 0 4.19 (0.19; 94) 0.4
Conduction disturbances 0 0 0 – –
ST-T changes 30 (85.7%) 17 (85%) 13 (86.7%) 0.87 (0.13; 6) 0.7
ST depression 11 (31.4%) 5 (25%) 6 (40%) 0.5 (0.12–2.12) 0.6
ST elevation 23 (65.7%) 14 (70%) 9 (60%) 1.55 (0.38–6.4) 0.8
ACS — acute coronary syndrome; OR — odds ratio; CI — confidence interval; hsTnT — high-sensitivity troponin T; CK — creatine kinase; CK-MB — creatine kinase isoenzyme MB; NT-proBNP — N-terminal type B 
natriuretic propeptide; LVEF — left ventricular ejection fraction
Discussion
The aim of the study was to identify easily accessible clinical 
parameters that would identify patients with myocarditis 
among young adults with chest pain. In our study, such 
determinants were inflammation-related parameters.
These findings are consistent with literature data, as 
myocarditis is most commonly caused by an infection 
(usually viral), and much less frequently by allergens, au-
toimmune diseases and toxic substances including medi-
cations [4, 5, 12, 13]. Prodromal symptoms of myocarditis 
depend on the site of infection (upper respiratory tracts or 
the gastrointestinal tract) and precede cardiac symptoms 
by several days to weeks [5, 13], which is also consistent 
with our observations.
Results of basic investigations including ECG, echocardio-
graphy, and laboratory markers of myocardial damage did not 
differentiate between various causes of chest pain, although 
dyslipidaemia was less frequently seen in our patients with 
myocarditis. These data are consistent with reports by other 
authors [14, 15] who indicated that the pathogenesis of ACS 
Figure 2. Admissions in relation to season; ACS — acute coronary 
syndrome
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Table 3. Burden of conventional cardiovascular risk factors
Parameter Overall Myocarditis ACS OR (95% CI) p
Smoking 4 (11.4%) 2 (10%) 2 (13.3%) 0.72 (0.09–5.8) 0.8
Hypertension 0 0 0 – –
Dyslipidaemia 11 (31.4%) 1 (5%) 10 (66.7%) 0.03 (0.003–0.3) 0.002
Obesity 4 1 (5%) 3 (20%) 0.21 (0.02–2.26) 0.2
Positive family history 18 8 (40%) 10 (66.7%) 0.33 (0.08–1.35) 0.1
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in young adults is related to the same conventional risk fac-
tors that lead to the development of coronary atherosclerosis 
and its clinical manifestations in older patients.
There are no clear diagnostic criteria of myocarditis 
based on non-invasive investigations. Indications for en-
domyocardial biopsy, long considered a diagnostic gold 
standard, are currently increasingly restricted to acute 
heart failure of unknown aetiology which is resistant to 
drug therapy, and heart failure symptoms of 2 weeks to 
3 months duration with left ventricular dilatation and new 
conduction disturbances or ventricular tachycardia, or 
when heart failure does not respond to standard therapy 
within 1–2 weeks [2, 5]. Thus, cardiac magnetic resonance 
imaging (MRI) is often suggested in patients with acute or 
persisting symptoms suggesting myocarditis, evidence of 
ongoing or recent myocardial damage, and suspicion of 
a viral aetiology of the condition [5].
These considerations also point to the main limitation 
of our study, i.e., lack of extended investigations in our 
patients. As cardiac MRI is not available in the emergency 
department, we were unable to verify the diagnosis of 
myocarditis, which was made by exclusion. Immunohisto-
chemical, molecular and serologic testing, which was also 
not performed in our patients, is mostly important for the 
purpose of identification of these patients who require 
specific immunomodulatory and immunosuppressive tre-
atment, while a large majority of patients with myocarditis 
respond to standard treatment of heart failure or conco-
mitant arrhythmia [5].
The purpose of our study was, however, to identify sim-
ple parameters which would be widely available in acute 
care settings and helpful for a physician trying to determine 
the cause of chest pain. When cardiac aetiology of the 
symptoms was confirmed, patients were referred to a car-
diac catheterization laboratory to exclude acute myocardial 
ischaemia. It has been shown that sequelae of an ACS in 
young patients are more severe, and outcomes are worse 
than in older age groups [14, 15]. Such an approach has 
been suggested in the current guidelines [5].
Conclusions
1. In young adults, causes of chest pain may be diffe-
rentiated based on a history of infection and elevated 
inflammatory markers (more frequent in patients 
with myocarditis), and the presence of dyslipidaemia 
(more frequent in patients with an acute coronary 
syndrome).
2. Evaluation of these simple parameters may guide furt-
her investigations in young patients with chest pain.
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Streszczenie
Wstęp. Zapalenie mięśnia sercowego jest często wyzwaniem diagnostycznym ze względu na niejednoznaczny obraz 
kliniczny. Ta zapalna choroba mięśnia sercowego powinna być rozpoznawana na podstawie określonych kryteriów kli-
nicznych, laboratoryjnych i wyników badań obrazowych.
Materiał i metody. Do badania włączano kolejnych chorych w wieku 18–40 lat, kierowanych na szpitalny oddział ra-
tunkowy z rozpoznaniem ostrego zespołu wieńcowego (ACS) w okresie od 1 stycznia 2011 roku do 31 grudnia 2013 
roku. Obok szczegółowego wywiadu chorobowego u każdego pacjenta oznaczano laboratoryjne markery uszkodzenia 
mięśnia sercowego i wykładniki stanu zapalnego oraz wykonywano elektrokardiografię (EKG) i echokardiografię (UKG). 
U wszystkich chorych wykonano angiografię naczyń wieńcowych. Rozpoznania zapalenia mięśnia sercowego dokonywa-
no z wykluczenia, na podstawie charakterystycznego wywiadu, objawów klinicznych, zmian w obrazach EKG i UKG oraz 
wyników badań laboratoryjnych, przy prawidłowym wyniku koronarografii.
Wyniki. Osoby z zapalenia mięśnia sercowego były znamiennie statystycznie młodsze (mediana wieku [Me] = 30,5; 
zakres międzykwartylowy [IQR] 20,5–32) niż chorzy z ACS (Me = 39; IQR 35–39,5) (p = 0,001). Wszyscy młodzi dorośli 
z rozpoznanym zapalenia mięśnia sercowego w ostatnich 4 tygodniach przebyli infekcję, najczęściej dróg oddechowych. 
Był to najsilniejszy determinant zapalenia mięśnia sercowego (iloraz czans [OR] = 113,7; 95-proc. przedział ufności [CI] 
5,64–2289,7; p < 0,001). Czas trwania infekcji wynosił 4 (IQR 3,5–7) dni. Osoby z zapaleniem mięśnia sercowego ce-
chowały się ponadto częstszym występowaniem gorączki w wywiadzie (OR = 17,22; 95%CI 0,9–330,5; p = 0,06), więk-
szą liczbą leukocytów w morfologii krwi obwodowej (Me = 9,95; IQR 8,3–11,95 v. Me = 8,2; IQR 6,4–10,32; p = 0,07) 
oraz podwyższonym stężeniem wysokoczułego białka C-reaktywnego (OR = 29,3; 95%CI 1,14–748,6; p = 0,04). Osoby 
z ACS cechowała znamiennie gorsza frakcja wyrzutowa lewej komory (Me = 60; IQR 60–65 v. Me = 55; IQR 50–55; 
p = 0,001), jednak nie przekładało się to na różnicę między grupami pod względem odsetka osób z obniżoną poniżej 
50% funkcją (OR = 0,34; 95%CI 0,03–4,2; p = 0,8). Obciążenie klasycznymi czynnikami ryzyka sercowo-naczyniowego 
nie różniło się między grupami, z wyjątkiem dyslipidemii, która u osób z zapaleniem mięśnia sercowego występowała 
znacznie rzadziej (OR = 0,03; 95%CI 0,003–0,3; p = 0,002).
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Wnioski. U młodych osób dorosłych czynnikami różnicującymi przyczynę stenokardii są infekcja w wywiadzie, podwyż-
szone parametry stanu zapalnego oraz obecność dyslipidemii.
Słowa kluczowe: zapalenie mięśnia sercowego, ostry zespół wieńcowy, młode osoby dorosłe
(Folia Cardiologica 2014; 9, 2: 120–125)
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Zapalenie mięśnia sercowego (myocarditis; MCI) — ze względu na zwykle skryty początek, 
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okres obserwacji szpitalnej nie pozwala na ustalenie rokowania. Zależy ono od wielu czynników, w tym schorzeń współ-
istniejących, a także indywidualizacji postępowania leczniczego. Brak opisu takiego postępowania stanowi istotne 
ograniczenie prezentowanych wyników tej ciekawej pracy oryginalnej. Warto w tym miejscu przytoczyć wyniki badań 
populacyjnych przeprowadzonych w trakcie pandemii grypy — obserwowano wciągnięcie serca w proces chorobowy 
w ostrej fazie choroby, natomiast po jej ustąpienie objawy kardiologiczne (dolegliwości stenokardialne, zaburzenia ryt-
mu, płyn w worku osierdziowym) całkowicie się cofały. Jedynie w ułamku procenta przypadków objawy te utrzymywały 
się przez dłuższy czas. Można zatem domniemywać, że dobre rokowanie u opisywanych chorych wynikało z wystąpienia 
u nich „odczynowej” reakcji zapalnej. Obserwuje się ją w mięśniach poprzecznie prążkowanych, często w formie uogól-
nionej. Niestety, jedynie przypadki odczynowej reakcji zapalnej leczą się samoistnie — przy założeniu, że u podłoża pro-
cesu chorobowego nie ma innej patologii serca. Przypadki zapalenia przewlekłego zwykle doprowadzają do rozwinięcia 
się kardiomiopatii zapalnej/pozapalnej. Niejednokrotnie — jak wskazują własne badania autopsyjne autora niniejszego 
komentarza — kończą się nagłym zgonem, najpewniej o etiologii arytmicznej. Należy jednak zaznaczyć, że nie ma, jak 
do tej pory, jednolitych kryteriów pozwalających na różnicowanie między ostrym a przewlekłym MCI.
Na kanwie pracy Gacha i wsp. można sobie zadać pytanie, czy zawsze należy wykonywać koronarografię w trybie pil-
nym, gdy istnieje podejrzenie stenokardialnej postaci MCI u osoby młodej lub bardzo młodej. Na tak postawione pyta-
nie nie ma jednoznacznej odpowiedzi. Jednak w świetle badań wskazujących na gorsze rokowanie i przebieg kliniczny 
ostrego niedokrwienia u osób młodych w porównaniu ze starszymi — jak zauważyli autorzy pracy — koronarografia staje 
się w tym przypadku podstawowym badaniem różnicującym potencjalny czynnik etiologiczny ostrego niedokrwienia.
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